Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J HIRSH

Showing results (631-640 of 666) with videos related to

Pageof 67
Sort By:
Circulation|April 15, 1995
A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosisP S Wells, P Brill-Edwards, P Stevens, et al.
Journal of Thrombosis and Haemostasis : JTH|December 1, 2009
Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trialJ A M Anderson, J Hirsh, S Yusuf, et al.
Journal of Thrombosis and Haemostasis : JTH|December 30, 2014
Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trialJ S Paikin, J Hirsh, J S Ginsberg, et al.
American Heart Journal|August 2, 2001
Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis)R J Peters, W Spickler, P Théroux, et al.
The Biochemical Journal|January 1, 1989
Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor XaF A Ofosu, J Hirsh, C T Esmon, et al.
Thrombosis and Haemostasis|November 1, 1991
The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional studyA A Long, J S Ginsberg, P Brill-Edwards, et al.
American Journal of Respiratory Cell and Molecular Biology|March 28, 2008
A2B adenosine receptors regulate the mucus clearance component of the lung's innate defense systemBrett M Rollins, Mellisa Burn, Ray D Coakley, et al.
The New England Journal of Medicine|December 30, 1982
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosisR Hull, J Hirsh, R Jay, et al.
Journal of the American College of Cardiology|March 27, 2001
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromesM C Bahit, E J Topol, R M Califf, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2013
A response to--there's madness in their methodsG Guyatt, J Eikelboom, M Crowther, et al.
Pageof 67

Showing results (631-640 of 666) with videos related to

Sort By:
Pageof 67
Circulation|April 15, 1995
A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosisP S Wells, P Brill-Edwards, P Stevens, et al.
Journal of Thrombosis and Haemostasis : JTH|December 1, 2009
Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trialJ A M Anderson, J Hirsh, S Yusuf, et al.
Journal of Thrombosis and Haemostasis : JTH|December 30, 2014
Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trialJ S Paikin, J Hirsh, J S Ginsberg, et al.
American Heart Journal|August 2, 2001
Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis)R J Peters, W Spickler, P Théroux, et al.
The Biochemical Journal|January 1, 1989
Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor XaF A Ofosu, J Hirsh, C T Esmon, et al.
Thrombosis and Haemostasis|November 1, 1991
The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional studyA A Long, J S Ginsberg, P Brill-Edwards, et al.
American Journal of Respiratory Cell and Molecular Biology|March 28, 2008
A2B adenosine receptors regulate the mucus clearance component of the lung's innate defense systemBrett M Rollins, Mellisa Burn, Ray D Coakley, et al.
The New England Journal of Medicine|December 30, 1982
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosisR Hull, J Hirsh, R Jay, et al.
Journal of the American College of Cardiology|March 27, 2001
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromesM C Bahit, E J Topol, R M Califf, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2013
A response to--there's madness in their methodsG Guyatt, J Eikelboom, M Crowther, et al.
Pageof 67